Azithromycin for mild-to-moderate COVID-19: author's reply
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2021
|
Summary: |
---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Elsevier
2021
|
Summary: |
---|